Glomerular expression of kidney injury molecule-1 and podocytopenia in diabetic glomerulopathy

American Journal of Nephrology

Volumn 34, Issue 3, 2011, Pages 268-280

  Zhao, Xueying ^a   Zhang, Yuanyuan ^a   Li, Lingyun ^a   Mann, David ^a   Imig, John D ^b   Emmett, Nerimiah ^a   Gibbons, Gary ^a   Jin, Li Ming ^c  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Albuminuria; Glomerulopathy; Kidney injury molecule 1; Parietal epithelial cells; Podocytes

Indexed keywords

ALBUMIN; KIDNEY INJURY MOLECULE 1; LOSARTAN; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BOWMAN CAPSULE; CLINICAL EVALUATION; CONTROLLED STUDY; DIABETIC NEPHROPATHY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALE; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEINURIA; RAT; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; CELL ADHESION MOLECULES; CELLS, CULTURED; DIABETIC NEPHROPATHIES; EPITHELIAL CELLS; KIDNEY GLOMERULUS; MALE; PODOCYTES; RATS; RATS, ZUCKER;

EID: 79961115589     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000330187     Document Type: Article

References (28)

1. de Zeeuw D, Remuzzi G, Parving HH, et al: Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy. Circulation 2004;110:921-927. (Pubitemid 39128617)
2. Siu B, Saha J, Smoyer WE, et al: Reduction in podocyte density as a pathologic feature in early diabetic nephropathy in rodents: prevention by lipoic acid treatment. BMC Nephrol 2006;7:6.
3. Stitt-Cavanagh E, MacLeod L, Kennedy C: The podocyte in diabetic kidney disease. Sci World J 2009;9:1127-1139.
4. Hoshi S, Shu Y, Yoshida F, et al: Podocyte injury promotes progressive nephropathy in Zucker diabetic fatty rats. Lab Invest 2002;82:25-35. (Pubitemid 34072643)
5. Ohse T, Vaughan MR, Kopp JB, et al: De novo expression of podocyte proteins in parietal epithelial cells during experimental glomerular disease. Am J Physiol Renal Physiol 2010;298:F702-F711.
6. Ohse T, Chang AM, Pippin JW, et al: A new function for parietal epithelial cells: a second glomerular barrier. Am J Physiol Renal Physiol 2009;297:F1566-F1574.
7. Suzuki T, Matsusaka T, Nakayama M, et al: Genetic podocyte lineage reveals progressive podocytopenia with parietal cell hyperplasia in a murine model of cellular/collapsing focal segmental glomerulosclerosis. Am J Pathol 2009;174:1675-1682.
8. Kramer AB, van Timmeren MM, Schuurs TA, et al: Reduction of proteinuria in adriamycin-induced nephropathy is associated with reduction of renal kidney injury molecule (Kim-1) over time. Am J Physiol Renal Physiol 2009;296:F1136-1145.
9. Bonventre JV: Kidney injury molecule-1 (KIM-1): a urinary biomarker and much more. Nephrol Dial Transplant 2009;24:3265-3268.
10. Ichimura T, Asseldonk EJ, Humphreys BD, et al: Kidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells. J Clin Invest 2008;118:1657-1668. (Pubitemid 351632370)
11. Yaoita E, Kurihara H, Sakai T, et al: Phenotypic modulation of parietal epithelial cells of Bowman's capsule in culture. Cell Tissue Res 2001;304:339-349. (Pubitemid 32480564)
12. Wang Y, Chen J, Chen L, et al: Induction of monocyte chemoattractant protein-1 in proximal tubule cells by urinary protein. J Am Soc Nephrol 1997;8:1537-1545. (Pubitemid 27496471)
13. Zoja C, Donadelli R, Colleoni S, et al: Protein overload stimulates RANTES production by proximal tubular cells depending on NF-kappa B activation. Kidney Int 1998;53:1608-1615. (Pubitemid 28243743)
14. Erkan E, De Leon M, Devarajan P: Albumin overload induces apoptosis in LLC-PK (1) cells. Am J Physiol Renal Physiol 2001;280:F1107-F1114.
15. Zhao X, Li LY: PPAR-alpha agonist fenofibrate induces renal CYP enzymes and reduces blood pressure and glomerular hypertrophy in Zucker diabetic fatty rats. Am J Nephrol 2008;28:598-606. (Pubitemid 351832447)
16. Sanden SK, Wiggins JE, Goyal M, et al: Evaluation of a thick and thin section method for estimation of podocyte number, glomerular volume, and glomerular volume per podocyte in rat kidney with Wilms' tumor-1 protein used as a podocyte nuclear marker. J Am Soc Nephrol 2003;14:2484-2493. (Pubitemid 37169334)
17. Canadillas S, Ortega R, Estepa JC, et al: Darbepoetin-alpha treatment enhances glomerular regenerative process in the Thy-1 glomerulonephritis model. Am J Physiol Renal Physiol 2010;299:F1278-F1287.
18. Ohse T, Pippin JW, Vaughan MR, et al: Establishment of conditionally immortalized mouse glomerular parietal epithelial cells in culture. J Am Soc Nephrol 2008;19:1879-1890.
19. Li L, Emmett N, Mann D, et al: Fenofibrate attenuates tubulointerstitial fibrosis and inflammation through suppression of nuclear factor-kappaB and transforming growth factor-beta1/Smad3 in diabetic nephropathy. Exp Biol Med (May wood) 2010;235:383-391.
20. Chaturvedi S, Farmer T, Kapke GF: Assay validation for KIM-1: human urinary renal dysfunction biomarker. Int J Biol Sci 2009;5:128-134.
21. Kramer AB, van der Meulen EF, Hamming I, et al: Effect of combining ACE inhibition with aldosterone blockade on proteinuria and renal damage in experimental nephrosis. Kidney Int 2007;71:417-424.
22. Kuehn EW, Park KM, Somlo S, et al: Kidney injury molecule-1 expression in murine polycystic kidney disease. Am J Physiol Renal Physiol 2002;283:F1326-F1336. (Pubitemid 35332662)
23. van Timmeren MM, Bakker SJ, Vaidya VS, et al: Tubular kidney injury molecule-1 in protein-overload nephropathy. Am J Physiol Renal Physiol 2006;291:F456-F464. (Pubitemid 44148135)
24. de Borst MH, van Timmeren MM, Vaidya VS, et al: Induction of kidney injury molecule-1 in homozygous Ren2 rats is attenuated by blockade of the renin-angiotensin system or p38 MAP kinase. Am J Physiol Renal Physiol 2007;292:F313-F320. (Pubitemid 46105271)
25. Kelly DJ, Aaltonen P, Cox AJ, et al: Expression of the slit-diaphragm protein, nephrin, in experimental diabetic nephropathy: differing effects of anti-proteinuric therapies. Nephrol Dial Transplant 2002;17:1327-1332. (Pubitemid 34812081)
26. Langham RG, Kelly DJ, Cox AJ, et al: Proteinuria and the expression of the podocyte slit diaphragm protein, nephrin, in diabetic nephropathy: effects of angiotensin converting enzyme inhibition. Diabetologia 2002;45:1572-1576.
27. Appel D, Kershaw DB, Smeets B, et al: Recruitment of podocytes from glomerular parietal epithelial cells. J Am Soc Nephrol 2009;20:333-343.
28. Yang Y, Gubler MC, Beaufils H: Dysregulation of podocyte phenotype in idiopathic collapsing glomerulopathy and HIV-associated nephropathy. Nephron 2002;91:416-423. (Pubitemid 34765239)